Danielle Matia Email and Phone Number

Knowledge of regulatory requirements of clinical trials initiated by UW faculty and commercial IRBs. Responsible for preparing and maintaining regulatory files, preparing initial submissions, drafting consent forms and other subject-facing documents, protocol modifications, and IRB continuing reviews and preparing IND application with the FDA.

Disease Research and Intervention Specialist (DRIS) – Term Limited Temporary ContractConducted notifiable disease surveillance and investigation, including implementation of disease control measures

Follow standard operating procedures (SOP) put in place by Pharmaceutical clients to:• Conduct yearly and mid-year audits pharmaceutical representatives sample supply• Conduct close out audits on behalf of pharma clients for pharmaceutical representatives shifting roles• Manage samples, marketing material and company equipment return logistic to pharmaceutical clients' designated location

• Managed strategic planning and implementation of the African Access Initiative (AAI), a partnership of companies, governments, healthcare providers, and NGOs, focused on sustainably expanding access to cancer medicines and technologies in five African countries namely Nigeria, Kenya, Cameroon, Rwanda and Cote d’Ivoire. • Managed relationship between BVGH and all partners involved in AAI implementation• Served as main point of contact for Ministries of Health representatives and Hospital Administrators

Built out, implemented, managed and led patient support and treatment access programs across Africa and the Middle East. Steward existing relationships and forged new public/private partnerships with cancer research organizations, key cancer researchers, thought leaders, and pharmaceutical companies (Novartis, Bristol-Meyer Squibb, Pfizer, Ariad). Set priorities and strategic direction for the organization’s activities in African and Middle East.· Worked closely with CEO researching new grant opportunities and developing grant proposals to expand the Africa region funding portfolio. · Established new patient support organizations in 15+ African countries. · Managed global oncology patient assistance programs for 5,000+ clients in 20+ countries in Africa. · Handled program administration activities, including defining project and program deliverables, developing project plans and budgets, and managing a team of 7 direct reports (Program · Officer and Program Coordinators). · Led commercialization, expansion, and utilization of Cepheid GeneXpert point of care diagnostic instrument in public hospitals in 10 countries in Africa, 5+ countries in South East Asia. · Developed and implemented the organization’s training strategy and capacity building workshops for Patient Support Organization leaders across Africa and the Middle East.· Grew the network of CML patients support organizations in Africa from 2 to 18.· Mentored 18 leaders of patient support organizations in Africa to advocate and lobby their local health authorities to improve patients’ access to treatment. · Organized, led, and managed biennial scientific workshops for 20+ African Hematologists participating in the Glivec International Patient Assistance Program.· Organized an annual African CML Patient Support Organization Leaders’ Training Conference - CML Life Africa - aimed at sharing best practices for health advocacy in the region.

Researcher analyzing behavioral, socio-demographic, situational and relational factors influencing women’s responses to HIV prevention opportunities offered at a public antenatal clinic in Abidjan (Ivory Coast). • Developed a coding scheme for all research-related qualitative data using ANSWR an open source coding software• Carried primary analysis to deciphering key data elements from CDC’s 1000+ qualitative surveys. • Assumed primary responsibility for translating and coding interviews completed in French. • Contributed to numerous research articles published in peer review journals. • Developed procedures to assess inter-coder reliability • Contributed to numerous research articles published in peer review journals:  Women's disclosure of actions to prevent mother-to-child HIV transmission (MTCT) in Abidjan, Cote d'Ivoire. Painter TM, Matia DM, Diaby KL, Sibailly TS, Lin LS, Kouassi MK, Ekpini ER, Roels TH, Wiktor SZ. Int Conf AIDS. 2002 Jul 7-12; 14: abstract no ThPpD2147Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. Thomas M Painter, Kassamba L Diaby, Danielle M Matia, Lillian S Lin, Toussaint S Sibailly, Moïse K Kouassi, Ehounou R Ekpini, Thierry H Roels, and Stefan Z Wiktor. BMJ, Sep 2004; 329: 543.Socio-demographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Côte d'IvoireTM Painter; K L Diaby; D M Matia; L S Lin; T S Sibailly; M K Kouassims; E R Ekpini; T H Roels; S Z Wiktor. International Journal of STD & AIDS, March 2005, 16(3): 237-242

Managed baseline surveys (data collection and analysis, etc.) on nutrition, family planning, immunization and sexually transmitted infections (including HIV/AIDS) in Central and Eastern Cameroon. • Managed secondary data collection for cooperative planning, monitoring and evaluation processes. • Authored final study reports enumerating findings and conclusions.

Trained field staff on the use and application of different tools and techniques of Participatory Rural Appraisal (PRA) methodologies

Project manger in charge of the training and supervising a team of seven in Participatory Rural Appraisal (PRA) in three villages in the outskirts of Bangui with the goal of gaining a better understanding indigenous forest management practices. Results of the study served as baseline for successfully introducing new agro-forestry practices in the study area.

Country Office Grant writer for Child Survival IX Project proposal.The proposal was highly rated by USAID/ Washington and the project was funded for four years.

Nutritional and market surveys on the availability of food items rich in vitamin A in the Far North Province of Cameroon.Identified children under five at risk of developing vitamin A deficiency by using a simplified dietary assessment questionnaire developed by the International Vitamin A Consultative Group (IVACG Method)